We describe the use of a combined gas chromatographic/ infrared/mass spectrometric system to identify some common, clinically important drugs. Sensitivity for the serially configured combined system is demonstrated to be in the low nanogram range for strong infrared-absorbing compounds. Unearity for cocaine in the infrared detector was shown to have a correlation coefficient of 0.9914. Vapor-phase infrared spectra are shown to be very reproducible, which is important in identifying drugs such as the barbiturates. Finally, the two completely independent principles of infrared and mass spectral detection lend significant confidence to the correct identification of the various drugs from a single injection of sample. 
(2).
We describe here the use of a combined system consisting of the Hewlett-Packard 5965A Infrared Detector (IRD) and the Hewlett-Packard 5970B Mass Selective Detector (MSD) for the unambiguous identification of a variety of hypnotic sedative drugs. In previous work (2) this combined system was used to investigate amphetamine and some of its "designer drug" analogs. The two independent dimensions of infrared and mass spectrometric data provide the highest confidence available for identification of drugs by use of a single injection into a gas chromatograph. ature of 250 #{176}C. The gas chromatograph oven was programmed from 70 to 275 #{176}C, at 15 #{176}C/min. Detector resolution was 4 wavenumbers.
Materials and Methods

Reagents
Instrumentation.
The instrumentation consisted of the HP 5965A IRD and the HP 5970B MSD. Each of the detectors is controlled by an HP Chemstation, consisting of an HP 9000 Series 300 computer and HP 7957B 81-megabyte disc drive. The gas chromatograph is the HP 5890A, and the chromatographic column is 25-m HP-5 (SE-54), 0.32 mm i.d., with 0.52-.an film thickness.
The configuration used for this analysis is a serial arrangement in which the gas-chromatographic effluent is directed first to the flow cell of the IRD and then to the MSD. The IRD/MSD interface utilizes 1.1 m of a 0.1-mm (i.d.) fused-silica capillary column extending from the IRD flow cell directly to the MSD source. This small-diameter transfer line acts as a restnctor, allowing less than 1 mL/ mm into the MSD. The total flow in the flow cell is about 4 mL/min, which includes both carrier gas and a sweep gas to enhance chromatographic resolution. The excess gas from the flow cell is vented or can be directed to a flame ionization detector. The system thus has, in effect, an open split interface in the flow cell. This serial configuration has the advantage that all of the gas-chromatographic effluent is directed to the IRD, which, depending on the particular compound, is about five-to 10-fold less sensitive than the scanning MSD. Approximately 6s is required for the peaks to travel from the IRD flow cell to the MSD. The IRD flow cell was at 300 #{176}C and a wide-band mercury-cadmium telluride (MCT) detector was utilized, having a spectral range of 4000 to 550 wavenumbers.
Results and DiscussIon
Sensitivity of the Combined GC/IR/MS System Figure 1 capability, we conducted a study on one of the drug mix components, cocaine. Figure 2 shows a plot of IRD total response (gas-chromatographic peak height) vs the concentration of cocaine. As can be seen, the linearity is very good, the correlation coefficient being 0.99 14. In terms of sensitivity, identifiable cocaine spectra were obtained at the 20-ng level, as shown in Figure 3 .
Confirmation of Drug Identity
There is considerable similarity in the spectra of the barbiturates in Figure 1 . Owing to the complementary nature of the IR and MS data, however, the combined system allows differentiation of all of the compounds. At first glance the differences are not obvious for two of these compounds, amobarbital and pentobarbital. Both the JR and MS spectra for them appear very similar to one another (3). However, expanding some regions of the JR spectrum, as shown in Figure 4 , reveals some definite differences.
That such slight differences can be useful is an important benefit of vapor-phase infrared spectra. Because these spectra are generated from compounds that are freely rotating and isolated from each other in the gas phase, they are inherently reproducible, both from instrument to instrument and from time to time. Thus, effects of the sample matrix are virtually eliminated by the gas-chromatographic separation of components before they reach the infrared detector. This is demonstrated for an automated series of replicate runs in Table 1 . Under auto sequence and macro programming control, the IRD system obtained the spectra of each peak in the run and plotted them. All In addition, the combined system can provide a combined library search report, as exemplified in Figure 5 for amobarbital. The report provides three classes of library "hits." Compounds appearing in class 1, where both the IR and MS library searches found the same result, is very strong evidence for identity. The completely independent scientific principles of infrared absorption and mass fragmentation provide high-confidence compound identification in complex unknown mixtures. For the amobarbital a mass spectral hit quality of 83 out of a possible 100 was obtained. The infrared hit quality was 966, with a perfect match being 1000. It should be noted that, even though the mass and infrared spectra of the barbiturates are very similar, the search algorithms are able to identify all of the compounds correctly.
In summary, the present system is a valuable tool in drug identification.
When two independent means of identification are utilized, the confidence level of the analysis is greatly enhanced.
The combined JRDIMSD system can render these highly reliable results by providing the complementary infrared and mass spectral data for each cornponent in complex mixtures.
In addition, the very high degree of reproducibility of vapor-phase infrared spectra makes it a strong asset in exact elucidation of structure. The system is especially valuable in cases where either technique alone cannot provide an unambiguous answer.
This situation can arise for drugs that can exist in isomeric forms resulting in nearly identical mass spectra or for a drug family comprising a homologous series, which can have very similar infrared spectra.
